InsiderOther

Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. Insider Trading Activity

Every SEC Form 4 transaction reported by Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd., sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. buying or selling?

Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. reported 3 open-market buys ($15.4M) and 49 sells ($116.3M) across 52 Form 4 filings at 5 companies — a net selling position of $100.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of Apr 7, 2022)

Total Form 4 filings
52
SEC EDGAR
Companies
5
Buys (3)
$15.4M
Sells (49)
$116.3M

Insider sentiment

Net selling

Net insider flow of $100.9M in net selling, filed between May 13, 2019 – Apr 7, 2022.

Companies Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. files for

#CompanyForm 4 filings
1MORFMorphic Holding, Inc.40
2NUVBNuvation Bio Inc.6
3GOSSGossamer Bio, Inc.4
4KRONKronos Bio, Inc.1
5TRVITrevi Therapeutics, Inc.1

Recent Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. transactions

DateTickerRoleTypeSharesValue
Apr 7, 2022NUVB10% OwnerSale2.5M$14.0M
Dec 17, 2021NUVB10% OwnerSale500.0K$5.0M
Dec 9, 2021NUVB10% OwnerSale1.4M$13.7M
Nov 24, 2021NUVB10% OwnerSale295.0K$2.9M
Nov 5, 2021NUVB10% OwnerSale2.0M$18.5M
Nov 1, 2021NUVB10% OwnerSale1.1M$10.2M
May 3, 2021MORFDirectorSale17.2K$937.7K
Apr 29, 2021MORFDirectorSale10.7K$593.3K
Apr 27, 2021MORFDirectorSale13.8K$773.8K
Apr 23, 2021MORFDirectorSale19.8K$1.1M
Apr 21, 2021MORFDirectorSale17.9K$970.5K
Apr 19, 2021MORFDirectorSale17.7K$987.1K
Apr 15, 2021MORFDirectorSale20.9K$1.2M
Apr 13, 2021MORFDirectorSale24.8K$1.4M
Apr 9, 2021MORFDirectorSale26.7K$1.6M
Apr 7, 2021MORFDirectorSale20.4K$1.3M
Apr 2, 2021MORFDirectorSale30.4K$1.9M
Mar 31, 2021MORFDirectorSale36.1K$2.2M
Mar 29, 2021MORFDirectorSale47.9K$2.8M
Mar 25, 2021MORFDirectorSale52.3K$3.2M
Mar 23, 2021MORFDirectorSale25.8K$1.6M
Mar 19, 2021MORFDirectorSale35.9K$2.3M
Mar 17, 2021MORFDirectorSale64.4K$4.2M
Mar 1, 2021MORFDirectorSale36.0K$1.3M
Feb 25, 2021MORFDirectorSale10.5K$360.3K

Showing the 25 most recent filings of 52. Screen every filing.

Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. insider trading FAQ

Is Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. buying or selling?

Across 52 SEC Form 4 filings, Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. reported 3 open-market purchases totaling $15.4M and 49 sales totaling $116.3M — a net selling position of $100.9M.

Which companies does Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. file Form 4s for?

Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. has reported insider transactions at 5 companies, most often Morphic Holding, Inc. (MORF), Nuvation Bio Inc. (NUVB), Gossamer Bio, Inc. (GOSS), Kronos Bio, Inc. (KRON), Trevi Therapeutics, Inc. (TRVI).

How far back does Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd.'s filing history go?

Trabud holds Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd.'s SEC Form 4 filings from May 13, 2019 – Apr 7, 2022, sourced directly from SEC EDGAR.

Where does Trabud get Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd.'s insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Omega Fund V, L.P. / Omega Fund V GP, L.P. / Omega Fund V GP Manager, Ltd. and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener